Sunday 19 May, 2024 01:42 AM
Site map | Locate Us | Login
   Kirloskar Ferrous Q4 PAT drops 81% YoY to Rs 18 cr    ZEEL reports turnaround Q4 numbers    NHPC Q4 PAT slides 18% to Rs 610 cr    Nestle India ends higher after public shareholders reject royalty hike proposal to Swiss parent    Sobha Q4 PAT drops 85% YoY to Rs 7 cr    Kirloskar Ferrous Industries Ltd leads losers in 'A' group    Vindhya Telelinks Ltd leads losers in 'B' group    Volumes soar at MTAR Technologies Ltd counter    Godrej Inds slides on reporting net loss of Rs 312 cr in Q4    Granules India Ltd gains for third consecutive session    Glenmark Pharmaceuticals Ltd up for third straight session    Aurobindo Pharma Ltd spurts 3.21%    National Aluminium Company Ltd gains for third straight session    Zee Entertainment Enterprises Ltd spurts 4.37%    Ashok Leyland Ltd up for third consecutive session 
Saravan Stocks
       
Company News
Kabra Drugs Ltd
Kabra Drugs Ltd - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday I.E. January 23 2024.
Jan 18,2024   Hrs IST

KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2024 inter alia to consider and approve We are pleased to inform you that the meeting of the Board of Directors of KABRA DRUGS LIMITED is scheduled to be held on Tuesday i.e. January 23 2024 at the Registered office of the Company situated at Shop No. 270 Shastri Market Indore Madhya Pradesh 452001 India. inter alia to consider and approve the following matters: To consider and approve proposal of fund raising by issue of equity shares or any other permitted mode through Preferential Allotment/Private Placement basis to the Non-Promoter / Public Category of investors in accordance with the provision of the Companies Act 2013 and SEBI (Issue of Capital and Disclosure Requirements Regulation 2018 as amended subject to regulatory or statutory approvals as may be required including the approval of the shareholders of the Company. Increase in Authorised Share Capital of the company from Rs.5 crores to Rs.16 Crores. Any other matter with permission of the Chairman.

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 32681913
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd